A randomized controlled trial to compare the effects of sulphonylurea gliclazide MR (modified release) and the DPP-4 inhibitor vildagliptin on glycemic variability and control measured by continuous glucose monitoring (CGM) in Brazilian women with type 2 diabetes

Daher Vianna Andre Gustavo; Lacerda Claudio Silva; Pechmann Luciana Muniz; Polesel Michelle Garcia; Marino Emerson Cestari; Faria-Neto Jose Rocha

首页> 外文期刊>Diabetes research and clinical practice >A randomized controlled trial to compare the effects of sulphonylurea gliclazide MR (modified release) and the DPP-4 inhibitor vildagliptin on glycemic variability and control measured by continuous glucose monitoring (CGM) in Brazilian women with type 2 diabetes

【24h】

A randomized controlled trial to compare the effects of sulphonylurea gliclazide MR (modified release) and the DPP-4 inhibitor vildagliptin on glycemic variability and control measured by continuous glucose monitoring (CGM) in Brazilian women with type 2 diabetes

机译：一种随机对照试验，可比较磺酰脲甲基甲基MR（修饰释放）和DPP-4抑制剂Vildagliptin对血糖监测（CGM）在2型糖尿病患者中连续葡萄糖监测（CGM）测量的血糖变异性和对照的影响

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aims: This study aims to evaluate whether there is a difference between the effects of vildagliptin and gliclazide MR (modified release) on glycemic variability (GV) in women with type 2 diabetes (T2DM) as evaluated by continuous glucose monitoring (CGM).

机译：目的：本研究旨在评估Vilyagliptin和Gliclazide Mr（修饰释放）对患有2型糖尿病（T2DM）的血糖变异性（GV）的血糖变异（GV）之间是否存在差异，如连续葡萄糖监测（CGM）评估的。

著录项

来源
《Diabetes research and clinical practice》 |2018年第2018期|共9页
作者
Daher Vianna Andre Gustavo; Lacerda Claudio Silva; Pechmann Luciana Muniz; Polesel Michelle Garcia; Marino Emerson Cestari; Faria-Neto Jose Rocha;
展开▼
作者单位

Pontificia Univ Catolica Parana Rua Imaculada Conceicao 1155 Bloco Med Curitiba Parana Brazil;

Hosp Nossa Senhora Gracas Div Endocrinol Curitiba Diabet Ctr Rua Alcides Munhoz 433 4 Andar BR;

Hosp Nossa Senhora Gracas Div Endocrinol Curitiba Diabet Ctr Rua Alcides Munhoz 433 4 Andar BR;

Hosp Nossa Senhora Gracas Div Endocrinol Curitiba Diabet Ctr Rua Alcides Munhoz 433 4 Andar BR;

Hosp Nossa Senhora Gracas Div Endocrinol Curitiba Diabet Ctr Rua Alcides Munhoz 433 4 Andar BR;

Pontificia Univ Catolica Parana Rua Imaculada Conceicao 1155 Bloco Med Curitiba Parana Brazil;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词
Continuous glucose monitoring; Gliclazide MR; Glycemic variability; Mean amplitude of glycemic excursions; Type 2 diabetes; Vildagliptin;

机译：连续葡萄糖监测;Gliclazide Mr;血糖变异性;平均血糖偏移的振幅;2型糖尿病;Vildagliptin;
入库时间 2022-08-20 08:20:06

相似文献

外文文献
中文文献
专利

1. A randomized controlled trial to compare the effects of sulphonylurea gliclazide MR (modified release) and the DPP-4 inhibitor vildagliptin on glycemic variability and control measured by continuous glucose monitoring (CGM) in Brazilian women with type 2 diabetes [J] . Daher Vianna Andre Gustavo, Lacerda Claudio Silva, Pechmann Luciana Muniz, Diabetes research and clinical practice . 2018,第期

机译：一种随机对照试验，可比较磺酰脲甲基甲基MR（修饰释放）和DPP-4抑制剂Vildagliptin对血糖监测（CGM）在2型糖尿病患者中连续葡萄糖监测（CGM）测量的血糖变异性和对照的影响
2. Effects of vildagliptin compared with glibenclamide on glucose variability after a submaximal exercise test in patients with type 2 diabetes: study protocol for a randomized controlled trial, DIABEX VILDA [J] . Aline Fofonka, Jorge P Ribeiro, Karina R Casali, Trials . 2014,第1期

机译：维格列汀与格列本脲相比对2型糖尿病患者进行次最大运动试验后葡萄糖变异性的影响：一项随机对照试验的研究方案DIABEX VILDA
3. Effects of luseogliflozin, a sodium-glucose co-transporter 2 inhibitor, on 24-h glucose variability assessed by continuous glucose monitoring in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, crossover study [J] . Nishimura R., Osonoi T., Kanada S., Diabetes, obesity & metabolism . 2015,第8期

机译：通过持续监测血糖对日本2型糖尿病患者进行评估，钠葡萄糖共转运蛋白2抑制剂luseogliflozin对24小时葡萄糖变异性的影响：一项随机，双盲，安慰剂对照，交叉研究
4. Assessing Glycemic Control in Diabetes: From Self Monitoring of Blood Glucose to Continuous Glucose Monitoring System [C] . M. Gribovschi, A. Fodor, G. Grosu, International conference on advancements of medicine and health care through technology . 2009

机译：评估糖尿病患者的血糖控制：从血糖自我监测到连续血糖监测系统
5. A 4-month randomized controlled clinical trial of adjuvant Exenatide or Pramlintide versus insulin alone in pediatric type 1 diabetes mellitus: Effect on glycemic control. [D] . Withycombe, Sarah Elizabeth. 2010

机译：儿科1型糖尿病患者中艾塞那肽或普兰林肽与单独使用胰岛素的4个月随机对照临床试验：对血糖控制的影响。
6. A randomized controlled trial comparing the effects of dapagliflozin and DPP-4 inhibitors on glucose variability and metabolic parameters in patients with type 2 diabetes mellitus on insulin [O] . Hiroshi Nomoto, Hideaki Miyoshi, Hajime Sugawara, 2017

机译：比较达格列净和DPP-4抑制剂对2型糖尿病胰岛素患者血糖变异性和代谢参数影响的随机对照试验
7. A randomized controlled trial comparing the effects of dapagliflozin and DPP-4 inhibitors on glucose variability and metabolic parameters in patients with type 2 diabetes mellitus on insulin [O] . Nomoto, Hiroshi, Miyoshi, Hideaki, Sugawara, Hajime, 2017

机译：比较达格列净和DPP-4抑制剂对2型糖尿病胰岛素患者血糖变异性和代谢参数影响的随机对照试验

A randomized controlled trial to compare the effects of sulphonylurea gliclazide MR (modified release) and the DPP-4 inhibitor vildagliptin on glycemic variability and control measured by continuous glucose monitoring (CGM) in Brazilian women with type 2 diabetes

摘要

著录项

相似文献

相关主题

期刊订阅